Empagliflozin and Metformin Extended-Release Tablets and Mogamulizumab
Determining the interaction of Empagliflozin and Metformin Extended-Release Tablets and Mogamulizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and metformin, Empagliflozin and Metformin
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and Metformin Extended-Release Tablets-Mogamulizumab-kpkc
- Empagliflozin and Metformin Extended-Release Tablets-Mogamulizumab-kpkc Intravenous
- Empagliflozin and Metformin Extended-Release Tablets-Molindone
- Empagliflozin and Metformin Extended-Release Tablets-Mometasone (Oral Inhalation)
- Empagliflozin and Metformin Extended-Release Tablets-Mometasone and Formoterol
- Empagliflozin and Metformin Extended-Release Tablets-Mometasone and formoterol Inhalation
- Mogamulizumab-Empagliflozin and Metformin Tablets
- Mogamulizumab-Empliciti
- Mogamulizumab-Emsam
- Mogamulizumab-Emsam Transdermal
- Mogamulizumab-Emtricitabine
- Mogamulizumab-Emtricitabine and tenofovir